F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

Health
By Andrew Jacobs from NYT Health https://ift.tt/V5zRFSY
via IFTTT Psychedelic and Hallucinogenic Drugs, Regulation and Deregulation of Industry, Psilocybin Mushrooms, Post-Traumatic Stress Disorder, Veterans, Therapy and Rehabilitation, Psychology and Psychologists, Mental Health and Disorders, Clinical Trials, Drugs (Pharmaceuticals), Ecstasy (Drug), Research, LSD (Lysergic Acid Diethylamide) The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda